A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol (GWP42003-P)
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Cannabidiol (Primary) ; Clobazam
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors GW Pharmaceuticals
- 31 Jul 2017 Status changed from active, no longer recruiting to completed.
- 17 Mar 2017 Planned primary completion date changed from 1 May 2017 to 1 Jul 2017.
- 14 Jul 2016 Status changed from not yet recruiting to active, no longer recruiting.